Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas

This work improves understanding of therapeutic resistance in rrDLBCL and has identified novel therapeutic opportunities especially for the high-risk patients with GCB-type rrDLBCL.